
ManageEngine Patch Manager Plus
Automated Linux Patch Management

SelfDecode
Genomelink
Whole Genome Sequencing for $299
Family Tree DNA
FDNA Face2Gene RESEARCH
Geni
Genomelink Open Biobank
Upload the 23andMe, AncestryDNA or MyHeritage file you already own and get sourced, CPIC-based answers about your medications.

Which is more popular?
Website, pricing, platforms and company facts side by side.
|
|
|
|
|---|---|---|
| Website | linuxpatch.com | decodemybio.com |
| Pricing | ||
| Platforms | ||
| Company | Startup from the United Kingdom · 2024 | — |
| Listed in |
In their own words, as submitted to SaaSHub.


LinuxPatch.com: Streamline Your Linux Patch Management LinuxPatch.com offers an intuitive, automated solution for managing patches across multiple Linux distributions, ensuring your servers stay secure and up-to-date. Key Features: One-Click Updates: Apply updates swiftly with a single click,...
DecodeMyBio reads a raw DNA file you already own — from 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA or Living DNA — and turns it into genotype-aware answers about the medications you take. No new test, no new sample. Guidance is tied to CPIC, DPWG and FDA sources, and covers the 128 drug-gene...
What each product offers, as listed by its team.


An editorial look at what each product does well and who it suits.


Overall verdict
Why this product is good
Recommended for
Overall verdict
Why this product is good
Recommended for
How often each product is chosen within a category, 0–100% relative to the other.


As answered by people managing LinuxPatch.com and DecodeMyBio.
LinuxPatch.com's answer
LinuxPatch.com stands out due to its comprehensive, user-friendly approach to Linux patch management. Unlike other tools, it offers one-click updates, AI-powered CVE reporting, and a unique autopilot feature that automates patching across multiple Linux distributions. The platform also supports server grouping for targeted updates, ensuring efficient management even in complex environments. Additionally, its health checks monitoring feature ensures that systems remain stable post-update, making it an ideal solution for businesses prioritizing security and operational efficiency.
DecodeMyBio's answer:
DecodeMyBio focuses specifically on how your genes affect your response to medications, not generic trait reports. It reads a raw DNA file you already own — 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA or Living DNA — and answers questions about the drugs you take, tied to CPIC, DPWG and FDA sources across the 128 drug-gene pairs CPIC grades as actionable at Level A and B. Two things set it apart. First, results are an interactive dashboard with an AI assistant that cites its sources, not a static PDF. Second, it is explicit about the limits of your data: a consumer genotyping array cannot fully call CYP2D6, for example, and DecodeMyBio says so rather than guessing past the file. Access is a one-time $59 purchase you keep for life; the only recurring option is Decode+ Monitoring, which re-checks your saved medications when CPIC guidance changes.
LinuxPatch.com's answer
LinuxPatch.com offers a distinctive blend of simplicity and power that sets it apart from competitors. Its one-click updates and autopilot feature simplify patch management, while AI-powered CVE reporting ensures you’re always ahead of potential threats. The platform supports multiple Linux distributions and includes server grouping for targeted updates, making it versatile for different environments. Health checks post-update provide added peace of mind, ensuring your systems remain stable and secure. For businesses seeking efficiency and robust security, LinuxPatch.com is the clear choice.
DecodeMyBio's answer:
Most DNA upload tools lead with ancestry or broad wellness traits. DecodeMyBio is built around prescribing decisions: it tells you how you are likely to respond to specific medications, backed by CPIC, DPWG and FDA guidance rather than general associations. It works from a file you already own, so there is no new test and no wait. It is also honest about what your file cannot support — array data cannot fully call CYP2D6, and the product marks that rather than filling the gap with a guess. Pricing is a one-time $59 for lifetime access instead of a mandatory subscription; monitoring for guideline changes is an optional add-on. Your data stays encrypted at rest and in transit, is never sold or shared with insurers or employers, and you can delete your genetic data at any time.
LinuxPatch.com's answer
The primary audience for LinuxPatch.com consists of IT administrators, DevOps professionals, and security teams managing Linux-based servers and infrastructures. These individuals are responsible for maintaining system security, ensuring uptime, and managing patching processes across various Linux distributions. They prioritize automation, efficiency, and security in their workflows and seek tools that simplify patch management while providing robust protection against vulnerabilities. Businesses, especially those with complex or large-scale Linux environments, will find LinuxPatch.com particularly beneficial.
DecodeMyBio's answer:
People who already hold a consumer DNA file — 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA or Living DNA — and want to use it for medication decisions. That includes anyone starting a new medication who wants to check genetic compatibility, people dealing with unexplained side effects or a drug that simply did nothing, and those who prefer data-driven prescribing over trial and error. Many of them arrive holding a 23andMe export they downloaded before the company's bankruptcy and want a real home for it. Findings are written to be brought to a prescriber, with the gene, variant and published guideline shown for each one.
LinuxPatch.com's answer
LinuxPatch.com was born out of a need for a more efficient and user-friendly solution to managing Linux patches across diverse environments. The founders, experienced in IT and cybersecurity, recognized the challenges organizations face in keeping their Linux systems up-to-date and secure. They aimed to create a tool that simplifies this process through automation, AI-powered vulnerability management, and an intuitive interface. Their goal was to empower IT teams to maintain robust security with minimal manual intervention, leading to the creation of LinuxPatch.com.
DecodeMyBio's answer:
DecodeMyBio started from a simple observation: millions of people have a raw DNA file sitting in a downloads folder doing nothing, and the most useful thing in that file has almost nothing to do with ancestry. It is pharmacogenomics — how your body actually processes the drugs you are prescribed. That evidence is public and clinical-grade (CPIC, DPWG, FDA), yet almost nobody outside a hospital ever gets it applied to their own genotype.
The 23andMe bankruptcy made it urgent. The company was sold to the nonprofit TTAM Research Institute and AncestryHealth was retired, which left a lot of people holding an export from a service that no longer stands behind it. The file still works. It just needed somewhere to go.
The product was rebuilt once, deliberately. The first version sold static PDF reports, and that turned out to be the wrong shape: a PDF is frozen the moment it is generated, while the guidance built on top of your genotype is not. CPIC revises its recommendations, and an answer that was current when you downloaded it can quietly go stale. So DecodeMyBio became an interactive platform on top of an open genomics engine — you buy the interpretation once and keep it for life, and monitoring for guideline changes became a separate, optional layer rather than something bolted onto a document.
The other thing that shaped it was deciding to be honest about the limits. Consumer arrays cannot call everything — a full CYP2D6 read is the standard example — and it would have been easy to paper over that. Saying "your file cannot answer this, and here is why" turned out to be the most trusted part of the product.
LinuxPatch.com's answer
LinuxPatch.com is built using a modern stack of reliable and scalable technologies. It leverages a combination of cloud infrastructure for scalability and remote patch management, AI-driven algorithms for CVE vulnerability scanning and reporting, and lightweight, cross-platform agents for seamless deployment across various Linux distributions. The platform also integrates automated orchestration tools to streamline patch scheduling and execution. The focus on automation, security, and multi-distro support makes LinuxPatch.com a highly efficient solution for managing Linux servers.
DecodeMyBio's answer:
A Python service layer behind a modern TypeScript web front end, on managed cloud infrastructure with a managed relational database.
The part that actually matters is the genomics layer. It is built on open bioinformatics tooling that parses the raw exports consumer testing services produce and calls pharmacogenomic phenotypes from them, on top of published clinical references — CPIC, DPWG and FDA guidance, with ClinVar and gnomAD for variant significance and frequency. Those references are ingested as versioned releases rather than queried live, which is what makes it possible to re-run an old result against new guidance and say precisely what changed.
The assistant is a large language model, constrained to the user's own decoded data and required to cite the gene, variant and source behind anything it says.
Payments, transactional email and authentication use established third-party providers rather than anything home-grown.
LinuxPatch.com's answer
LinuxPatch.com serves a diverse range of customers, including large enterprises, financial institutions, and tech companies that require robust security and efficient management of their Linux infrastructures. While specific customer names are typically confidential, the platform is trusted by organizations that prioritize high levels of automation, security, and reliability in their IT operations. These customers rely on LinuxPatch.com to maintain the integrity of their systems and to ensure that their servers remain secure and up-to-date across various Linux distributions.
DecodeMyBio's answer:
DecodeMyBio is direct-to-consumer, so there is no roster of company customers to list here. Its users are individuals who already hold a consumer DNA export and want it applied to their own prescriptions — typically someone starting a new medication, someone who has had an unexplained side effect or a drug that simply did nothing, and people who downloaded a 23andMe export before the bankruptcy and want it to stay useful.
We also do not publish customer names, and that is deliberate rather than a gap. These are people's genetic and medication records; a pharmacogenomics product should not be turning its users into a logo wall or a testimonial list. Data is never sold, and never shared with insurers or employers.
Share your experience with using LinuxPatch.com and DecodeMyBio. For example, how are they different and which one is better?
When comparing LinuxPatch.com and DecodeMyBio, you can also consider the following products.

Patch Manager Plus, an all-round patching solution, offers automated patch deployment for Windows, macOS, and Linux endpoints, plus patching support for 350+ third-party applications You can use it to patch computers within LAN and WAN.
Compare ManageEngine Patch Manager Plus to LinuxPatch.com or DecodeMyBio:

Get personalized, genetics-based health reports.
Compare SelfDecode to LinuxPatch.com or DecodeMyBio: